advert
advert
Angel News

Back to Homepage

7th February 2018 - 0 comments

Exeter – Lessons in Disruption

Symvan was one of eight fund managers presenting in Sandy Park,Exeter on 5th December on the joys of tax-efficient fund investing. 

7th February 2018 - 0 comments

NVM invests £9 million in Dale Power Solutions

NVM Private Equity has backed a management buyout of Dale Power Solutions, a leading providers of reliable secure power solutions.

6th February 2018 - 0 comments

Maven opens Nottingham office

Investment team will support growth SMEs across the East and South-East Midlands, as part of the Midlands Engine Investment Fund (MEIF), supported by the European Regional Development Fund.

5th February 2018 - 0 comments

EIS & VCT changes - but what do they mean for my clients and me? Part 1

In the first of three articles on the changes brought in with the Budget, James Ramsay, a tax efficient specialist, takes an adviser’s eye view of the changes and their implications to firms and their clients.

1st February 2018 - 0 comments

Calculus Capital invests £30m in record year

Calculus Capital reported a record year in 2017, with £30m invested and over 500 companies reviewed over the 12 months to 31 October.

Calculus believes this is evidence of the strong appetite for EIS and VCT investments and the robust health of the UK’s SME sector, which provided the team with a diverse range of attractive opportunities across a broad spread of business areas.

John Glencross, Chief Executive of Calculus Capital, said: “We’ve been investing in SMEs for almost 20 years and have a highly experienced team, with very demanding investment criteria. The range and quality of opportunities we identified over this 12 month period, which is our financial year, was striking though.

22nd January 2018 - 0 comments

Maven investment honcho launches innovative new app

honcho, an innovative new app designed to reduce insurance costs for motorists launches following a successful crowdfunding campaign and an investment of £150,000 from the Finance Durham Fund, managed by Maven Capital Partners.

22nd January 2018 - 0 comments

Mobeus backs Proactive Investors for US launch

Mobeus Equity Partners has invested £3.3m of development capital in Proactive Investors, the leading provider of investor media services to mid- and small-cap listed companies in the UK.

17th January 2018 - 0 comments

Yoti successfully raises £8m equity investment

Yoti, a UK based digital identity platform, has raised £8m of equity investment from existing angel investors and two of the company’s three founders, Robin Tombs and Noel Hayden. This gives the company an enterprise valuation of £65m. Yoti will use these funds to grow its consumer network, with an aim of reaching 2 million users during 2018.

10th January 2018 - 0 comments

Maven Property has raised £4.6 million to fund the development of two residential property sites in Renfrew and Clackmannan in conjunction with Scottish housebuilder, Ambassador Homes (Ambassador). 

9th January 2018 - 0 comments

Maven Capital Partners has completed a £1.95 million investment in eSafe Global Limited, which monitors online user behaviour and cyber bullying within a school or college digital environment. 

7th January 2018 - 0 comments

Six in 3 weeks as YFM completes £100m of deals

If the adage about waiting for a bus holds true then the last three weeks has been a purple patch for YFM as the firm has realised four investments for up to 4.2x.

Combined with further investments into the remaining portfolio, total deal activity topped £100 million in December. The backcloth of the most uncertain times in the UK’s recent political history, has not dimmed the ability of the UK’s small businesses to generate value, employment and boost exports.

15th December 2017 - 0 comments

NVM backed Medovate to boost NHS medtech innovation

Backed by £9 million of investment capital from NVM Private Equity and a private US investor, Medovate is the first company dedicated to the development and commercialisation of innovative medical technologies from within the NHS, which will commercially benefit the NHS.

PREVIOUSItems 300 of 405NEXT

Back to Homepage